Evermay Wealth Management LLC Has $1.20 Million Holdings in Danaher Co. (DHR)
Evermay Wealth Management LLC raised its position in Danaher Co. (NYSE:DHR) by 85.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,874 shares of the conglomerate’s stock after purchasing an additional 5,944 shares during the period. Danaher accounts for 0.4% of Evermay Wealth Management LLC’s investment portfolio, making the stock its 26th biggest position. Evermay Wealth Management LLC’s holdings in Danaher were worth $1,195,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Calton & Associates Inc. bought a new stake in shares of Danaher during the 4th quarter worth $114,000. GQG Partners LLC bought a new stake in shares of Danaher during the 2nd quarter worth $101,000. First Personal Financial Services lifted its holdings in shares of Danaher by 128.9% during the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after acquiring an additional 691 shares during the last quarter. Zions Bancorporation lifted its holdings in shares of Danaher by 118.3% during the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after acquiring an additional 667 shares during the last quarter. Finally, Resources Investment Advisors Inc. lifted its holdings in shares of Danaher by 661.2% during the 4th quarter. Resources Investment Advisors Inc. now owns 1,530 shares of the conglomerate’s stock worth $142,000 after acquiring an additional 1,329 shares during the last quarter. 75.88% of the stock is owned by hedge funds and other institutional investors.
In other Danaher news, EVP William K. Daniel sold 131,066 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $102.05, for a total value of $13,375,285.30. Following the transaction, the executive vice president now owns 270,523 shares in the company, valued at $27,606,872.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The disclosure for this sale can be found here. Insiders sold 274,913 shares of company stock worth $27,729,293 in the last 90 days. Corporate insiders own 12.20% of the company’s stock.
Danaher Co. (NYSE:DHR) opened at $94.46 on Monday. The company has a market cap of $65,800.84, a price-to-earnings ratio of 26.76, a P/E/G ratio of 1.99 and a beta of 1.04. Danaher Co. has a 52-week low of $78.97 and a 52-week high of $104.82. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.43 and a quick ratio of 1.05.
Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The firm had revenue of $5.09 billion for the quarter, compared to analysts’ expectations of $4.97 billion. During the same quarter in the previous year, the company earned $1.05 earnings per share. The company’s revenue for the quarter was up 10.9% compared to the same quarter last year. analysts forecast that Danaher Co. will post 4.37 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Friday, December 29th were given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date of this dividend was Thursday, December 28th. Danaher’s payout ratio is 15.86%.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.